Results 81 to 90 of about 2,454,151 (187)

Demographic features of patients with neuromyelitis optica spectrum disorder and healthy controls.

, 2014
Abbreviations: NMOSD, neuromyelitis optica spectrum disorder; N, number; y, years; F, female; M, male; EDSS, expanded disability status scale; ARR, annualized relapse rate.aPatients meeting the revised diagnostic criteria for NMO [16].bExpressed as mean ±
Byoung Joon Kim (628408), Byung-Euk Joo (628405), Soo-Youn Lee (628407), Patrick Waters (445172), Angela Vincent (25668), Hye-Jin Cho (628404), Kwang Ho Lee (135038), Ju-Hong Min (628403), Sook-Young Woo (628406), Hee-Young Shin (562177)   +9 more
core   +1 more source

Paramagnetic Rim Lesions Are Associated With Trans‐Synaptic Degeneration of the Visual Pathway in Multiple Sclerosis

Annals of Clinical and Translational Neurology, Volume 13, Issue 9, Page 1831-1841, September 2026.
ABSTRACT Objectives Retrograde trans‐synaptic degeneration (rTSD) from posterior visual pathway lesions in multiple sclerosis (MS) is characterized by hemi‐macular ganglion cell‐inner plexiform layer (GCIPL) thinning and contralateral visual field loss.
Abdul Jaber Tayem, Angel Liu, Sargis Manukyan, Mustafa Subhi, Elaina Luskin, Bryan Quah, Sreekanth Madhusoodhanan Nair, Arzu C. Has Silemek, Gabriela Zabala, Yujie Cui, Laura Locke, Paula Barreras, Marwa Kaisey, Vinicius Calsavara, Daniel S. Reich, Nancy L. Sicotte, Pascal Sati, Omar Al‐Louzi   +17 more
wiley   +1 more source

Successful treatment for psychomotor agitation in neuromyelitis optica spectrum disorder with trazodone–risperidone combination: a case report

, 2017
Zui Narita,1 Harumasa Takano,1 Tomiki Sumiyoshi2 1Department of Psychiatry, National Center Hospital, 2Department of Clinical Epidemiology, Translational Medical Center, National Center of Neurology and Psychiatry, Tokyo, Japan Abstract: Neuromyelitis ...
Sumiyoshi T, Takano H, Narita Z
core  

Complexity and wide range of neuromyelitis optica spectrum disorders: more than typical manifestations

, 2017
Jinming Han,1 Meng-ge Yang,1 Jie Zhu,1,2 Tao Jin1 1Department of Neurology and Neuroscience Center, The First Hospital of Jilin University, Changchun, China; 2Department of Neurobiology, Care Sciences and Society, Karolinska Institute, Stockholm, Sweden
Jin, T, Zhu, J,, Zhu J, Yang M, Jin T, Han, J, Yang, M-G, Han J   +7 more
core   +1 more source

Clinical Validation of Plasma p‐217tau in Neurological Diseases

Annals of Clinical and Translational Neurology, Volume 13, Issue 9, Page 1780-1790, September 2026.
ABSTRACT Objective Plasma p‐217tau is a minimally invasive but specific biomarker for diagnosing Alzheimer's disease (AD). However, its disease specificity remains to be clinically evaluated. We validated the reliability of the p‐217tau biomarker in 12 other neurological diseases.
Takeshi Kawarabayashi, Takumi Nakamura, Ryoma Takahashi, Tetsuya Ueda, Seiji Kinoshita, Chikage Uchida, Takashi Sugawara, Kentaro Hashimoto, Kunihiko Ishizawa, Masakuni Amari, Hiroo Kasahara, Yoshio Ikeda, Masamitsu Takatama, Mikio Shoji   +13 more
wiley   +1 more source

Neuromyelitis optica spectrum disorder as a paraneoplastic manifestation of lung adenocarcinoma expressing aquaporin-4.

, 2015
Neuromyelitis optica spectrum disorder as a paraneoplastic manifestation of lung adenocarcinoma expressing aquaporin ...
Rindi, Guido, Di Iorio, Riccardo, Erra, Carmen, Sabatelli, Mario, Damato, Valentina, Ferilli, Michela, Ferilli, Michela Ada Noris, Iorio, Raffaele   +7 more
core   +1 more source

Efficacy of Inebilizumab in N‐MOmentum Trial Participants With or Without Prior Immunosuppressants

Annals of Clinical and Translational Neurology, Volume 13, Issue 9, Page 1930-1936, September 2026.
ABSTRACT This post hoc analysis examined the impact of prior immunosuppressants on the long‐term efficacy and safety of inebilizumab, a cluster of differentiation 19+ B‐cell–depleting monoclonal antibody, in participants with aquaporin‐4–seropositive neuromyelitis optica spectrum disorder from the N‐MOmentum trial (NTC02200770).
Bruce A. C. Cree, Beatrice Suero, Sarah Walsh, Romain Marignier, John W. Lindsey, Ho Jin Kim, Dewei She, Daniel Cimbora, Dustin Cavida, Friedemann Paul   +9 more
wiley   +1 more source

Neuromyelitis Optica Spectrum Disorder: A Clinical Review

Sclerosis
Neuromyelitis optica spectrum disorder (NMOSD) is an autoimmune astrocytopathy in which antibodies against the aquaporin-4 (AQP4) water channel produce a stereotyped group of syndromes determined by the anatomical distribution of AQP4 expression.
Abdulaziz Al Abdulghani, Steven L. Galetta   +1 more
doaj   +1 more source

Neuromyelitis optica spectrum disorder: a pediatric case report

Medicine Science, 2017
Neuromyelitis optica spectrum disorder(NMOSD) is an autoimmune demyelinating disorder of the central nervous system that predominantly affects the optic nerves and the spinal cord.
Mujgan Arslan, Serdal Gungor, Betul Kilic, Kader Karli Oguz   +3 more
doaj   +1 more source

Anti‐TNF‐Alpha Associated Central Nervous System Demyelination. Drug‐Induced Demyelination or Multiple Sclerosis Trigger? A Case Series

Clinical Case Reports, Volume 14, Issue 9, September 2026.
ABSTRACT Adalimumab is a monoclonal antibody that targets TNF‐α and is effective in treating several autoimmune disorders, including non‐infectious uveitis; however, it has been associated with demyelinating lesions. This study presents two cases of CNS demyelination in patients who consumed adalimumab. First, an 18‐year‐old man presented with subacute
Marzie Abutorabi‐zarchi, Amin Ziyaei, Davoud Ghane   +2 more
wiley   +1 more source